Dkk-related proteins
Abstract
Novel Dkk and Dkk-related polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Dkk and Dkk-related proteins, the invention further provides isolated fusion proteins, antigenic peptides and antibodies. The invention also provides Dkk and Dkk-related nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a Dkk and Dkk-related gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
Claims
exact text as granted — not AI-modified1 . An isolated protein comprising an amino acid sequence at least 90% identical to SEQ ID NO:14.
2 . The isolated protein of claim 1 , wherein the protein comprises an amino acid sequence at least 95% identical to SEQ ID NO:14.
3 . The isolated protein of claim 1 , wherein the protein comprises the amino acid sequence of SEQ ID NO:14.
4 . The isolated protein of claim 1 , wherein the protein is a fusion protein.
5 . The isolated protein of claim 1 , wherein the fusion protein comprises an immunoglobulin domain.
6 . The isolated protein of claim 1 , wherein the immunoglobulin domain is an Fc region.Join the waitlist — get patent alerts
Track US2010093978A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.